NASDAQ · Drug Manufacturers - Specialty & Generic
BioCryst Pharmaceuticals Inc (BCRX)
$8.55
+3.14%
49
In band
Moving averages
SMA 200$8.60-0.58%
Company profile
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$2.07B
P/E ratioNone
EPS$-1.40
Beta0.564
Dividend yield0.00%
52-week high$11.22
52-week low$6.00
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 57
CGC
Canopy Growth Corporation
RSI 28
BFRI
Biofrontera Inc
RSI 36
TLRY
Tilray Brands Inc - Class 2
RSI 33
LNTH
Lantheus Holdings Inc
RSI 48
ACB
Aurora Cannabis Inc
RSI 67
INM
InMed Pharmaceuticals Inc
RSI 50
ORGO
Organogenesis Holdings Inc - Class A
RSI 33
ZTS
Zoetis Inc - Class A
RSI 57
AQST
Aquestive Therapeutics Inc
RSI 52
RSI alerts for BCRX
Get an email the moment BioCryst Pharmaceuticals Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 6:34 AM EDT